  See all
 |
Articles: Neuro/Psych pharmacology |
Prior Articles
Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia
European Neuropsychopharmacology, 09/03/09
3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS
Muscle & Nerve, 09/03/09 DSM-IV Depression with Atypical Features: Is It Valid
Neuropsychopharmacology, 09/03/09 Amygdalocortical Circuitry in Schizophrenia: From Circuits to Molecules
Neuropsychopharmacology, 09/03/09 Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study
European Neuropsychopharmacology, 09/03/09 Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial
Journal of Clinical Oncology, 09/02/09 Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder
Pharmacoepidemiology and Drug Safety, 09/02/09 Adverse reactions to antidepressants
British Journal of Psychiatry, 09/02/09 Combined Corticosteroid and Antiviral Treatment for Bell Palsy: A Systematic Review and Meta-analysis
JAMA, 09/02/09 Gender differences in the use of anxiolytics and antidepressants: a population based study
Pharmacoepidemiology and Drug Safety, 09/02/09 An Open-label Study of Memantine Treatment in 3 Subtypes of Frontotemporal Lobar Degeneration
Alzheimer Disease & Associated Disorders, 09/02/09 Biovail Announces Results from ACADIAs Phase III Trial of Pimavanserin in Parkinsons Disease Psychosis
BioVail Corporation, 09/02/09
Free full text
Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid and Plasma in Patients with Tuberculous Meningitis
Clinical Infectious Diseases, 09/01/09 Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children
Developmental Medicine & Child Neurology, 08/31/09 Modulation of agonist binding to AMPA receptors by CX546: Differential effects across brain regions and GluA1-4/TARP combinations
Journal of Pharmacology and Experimental Therapeutics, 08/31/09 B-type natriuretic peptide as a marker of subclinical heart injury during mitoxantrone therapy in MS patients—Preliminary study
Clinical Neurology and Neurosurgery, 08/31/09 The Management of Amyotrophic Lateral Sclerosis
U.S. Pharmacist, 08/28/09
Free full text
Neurocircuitry of Addiction
Neuropsychopharmacology, 08/28/09 Cognitive Efficacy of Quetiapine and Olanzapine in Early-Onset First-Episode Psychosis
Schizophrenia Bulletin, 08/28/09 Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease
Amyotrophic Lateral Sclerosis, 08/28/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
